Moderate hyperhomocysteinaemia and immune activation in patients with rheumatoid arthritis
- 18 November 2003
- journal article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 338 (1-2) , 157-164
- https://doi.org/10.1016/j.cccn.2003.09.003
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremiaKidney International, 2001
- Hyperhomocysteinaemia in Behcet's diseaseRheumatology, 2001
- Abnormal homocysteine metabolism in rheumatoid arthritisArthritis & Rheumatism, 1997
- sIL-2R LEVELS IN RHEUMATOID ARTHRITIS: POOR CORRELATION WITH CLINICAL ACTIVITY IS DUE IN PART TO DISEASE DURATIONRheumatology, 1995
- A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakesPublished by American Medical Association (AMA) ,1995
- Redox Status and Protein Binding of Plasma Homocysteine and Other Aminothiols in Patients With Early-Onset Peripheral Vascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Circulating soluble tumor necrosis factor receptors, interleukin‐2 receptors, tumor necrosis factor α, and interleukin‐6 levels in rheumatoid arthritis.Arthritis & Rheumatism, 1993
- Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseasesArthritis & Rheumatism, 1992
- Elevated soluble interleukin‐2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritisArthritis & Rheumatism, 1988
- Urinary neopterin reflects clinical activity in patients with rheumatoid arthritisArthritis & Rheumatism, 1986